Cargando…
Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
The broad and potent tumor-reactivity of innate-like γδT cells makes them valuable additions to current cancer immunotherapeutic concepts based on adaptive immunity, such as monoclonal antibodies and αβT cells. However, clinical success using γδT cells to treat cancer has so far fallen short. Effort...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238375/ https://www.ncbi.nlm.nih.gov/pubmed/25477886 http://dx.doi.org/10.3389/fimmu.2014.00601 |